Cargando…
A first-year dornase alfa treatment impact on clinical parameters of patients with cystic fibrosis: the Brazilian cystic fibrosis multicenter study
OBJECTIVE: To describe the clinical impact of the first year treatment with dornase alfa, according to age groups, in a cohort of Brazilian Cystic Fibrosis (CF) patients. METHODS: The data on 152 eligible patients, from 16 CF reference centers, that answered the medical questionnaires and performed...
Autores principales: | Rozov, Tatiana, Silva, Fernando Antônio A. e, Santana, Maria Angélica, Adde, Fabíola Villac, Mendes, Rita Heloisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade de Pediatria de São Paulo
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183036/ https://www.ncbi.nlm.nih.gov/pubmed/24473945 http://dx.doi.org/10.1590/S0103-05822013000400002 |
Ejemplares similares
-
Nutrition in Cystic Fibrosis: as important as the management of pulmonary
disease
por: Adde, Fabíola Villac
Publicado: (2015) -
Dornase alfa in Cystic Fibrosis: indications, comparative studies and effects on lung clearance index
por: Terlizzi, Vito, et al.
Publicado: (2022) -
Dornase alpha use in patients with cystic fibrosis
por: Marostica, Paulo José C.
Publicado: (2013) -
Shwachman-Kulczycki score still useful to monitor cystic fibrosis severity
por: Stollar, Fabíola, et al.
Publicado: (2011) -
Effect of Dornase Alfa on the Lung Clearance Index in Children with Cystic Fibrosis: A Lesson from a Case Series
por: Terlizzi, Vito, et al.
Publicado: (2022)